NSE filing, NSE: BHARTIHEXA. Summary written from the filing by ALFA Finder's alert engine.
Bharti Hexacom Ltd: key numbers
- Share price
- ₹1,699.00
- Market cap
- ₹84,950 Cr
- Revenue (annual)
- ₹9,354 Cr
- Net profit (annual)
- ₹1,733 Cr
- P/E (TTM)
- 46.6×Sector 38.5×
- Promoter holding
- 70.00%+0.00% QoQ
- FII holding
- 3.25%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bharti Hexacom Ltd
All →Bharti Hexacom Management Change
Bharti Hexacom appointed Akhil Garg as Non-Executive Director and Amit Wadhwa as CEO and KMP. Soumen Ray and Marut Dilawari have ceased in these roles.
Bharti Hexacom Q2 FY27 Results: Net Profit ₹566.1 Cr, Up 34.4% YoY
Bharti Hexacom Ltd reported revenue from operations of ₹2,582 Cr (+11.4% YoY) and net profit of ₹566.1 Cr (+34.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹566.1 Cr · +34.4% YoY
Bharti Hexacom Other Announcement
Bharti Hexacom informed the exchanges that its RTA, KFin Technologies, will move its corporate office effective December 1, 2026. The registered office of the RTA is unchanged.
Bharti Hexacom Board Meeting Date
Bharti Hexacom will hold a board meeting on November 4-5, 2026, to consider audited results for the quarter and half year ended September 30, 2026. The meeting is not yet held, so no outcome is reported.
Bharti Hexacom Other Announcement
Bharti Hexacom Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Bharti Hexacom Annual General Meeting
Bharti Hexacom Limited held its 31st Annual General Meeting on August 11, 2026. The meeting covered financial adoption, dividend declaration, and various special business items.
Other results update announcements
All →Muthoot Microfin Results Update
Muthoot Microfin reported Q2 FY27 PAT of Rs. 110.8 crore, up 262.9% YoY, alongside a record Rs. 2,900 crore in disbursements. CareEdge revised its outlook to Positive.
Glenmark Pharmaceuticals Results Update
Glenmark Pharmaceuticals released its Q2 FY27 press release and MD&A for the quarter ended September 2026. Highlights show India growth and lower North America revenue.
Hindalco Industries Results Update
Hindalco filed Novelis's Q2 FY27 news release and earnings presentation, released on the subsidiary's website. The release highlights net sales up 25% year-on-year.
Ivalue Infosolutions Results Update
iValue Infosolutions released a press release on its unaudited Q2FY27 and half-year results ended 30 September 2026. The release highlights revenue, EBITDA and PAT growth quarter-on-quarter.
Indian Hume Pipe Company Results Update
Indian Hume Pipe's Q2 FY27 net profit fell to Rs.22.75 crore from Rs.34.69 crore, with revenue from operations down 21%. Half-year revenue from operations fell 12% year-on-year.
Protean eGov Technologies Results Update
Protean eGov reported Q2FY27 revenue of INR 271 crore, up 8% YoY, and PAT of INR 16 crore. The company stated it holds zero debt.